The evidence from clinical trials on Gout medicines effect on COVID‐19: A protocol for systematic review and meta‐analysis
Abstract Aim To evaluate the available evidence from clinical trials on the efficacy of gout medicines against COVID‐19. Design Systematic review and Meta‐analysis. Methods We are systematically searching five databases [PubMed, Embase, CT.gov, ICTRP, CINAHL (EBSCO)]. We are following the PRISMA sta...
Saved in:
Main Authors: | Ahmad Naoras Bitar (Author), Syed Azhar Syed Sulaiman (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2023-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Osteoporosis among patients with chronic obstructive pulmonary disease: Systematic review and meta-analysis of prevalence, severity, and therapeutic outcomes
by: Ahmad Naoras Bitar, et al.
Published: (2019) -
Prevalence, risk assessment, and predictors of osteoporosis among chronic obstructive pulmonary disease patients
by: Ahmad Naoras Bitar, et al.
Published: (2021) -
The association between chronic heroin smoking and chronic obstructive pulmonary disease
by: Ahmad Naoras Bitar, et al.
Published: (2021) -
Chinese herbal medicine for gout: a review of the clinical evidence and pharmacological mechanisms
by: Xiansu Chi, et al.
Published: (2020) -
Promising Adjunct Medicines in the Protocol of COVID-19 Clinical Trial
by: Mona Mahmoud AbouSamra, et al.
Published: (2022)